First registry-eligible patient procedure completed in RenovoRx's study
PositiveFinancial Markets

RenovoRx has successfully completed the first procedure for a patient eligible for its study, marking a significant milestone in their research. This achievement not only demonstrates the potential of their innovative treatment but also paves the way for future advancements in patient care. As the study progresses, it could lead to new therapies that improve outcomes for patients, making this a noteworthy development in the medical field.
— Curated by the World Pulse Now AI Editorial System